Who are we?

In 2025, the Consortium for Personalised Breast Cancer Prevention was established to implement a practical model for personalised breast cancer prevention in the United Kingdom. This initiative enables women to access personalised breast cancer risk assessments and tailored screening programmes through our partners.

Personalised Breast Cancer Prevention is a telemedicine service offered in collaboration with the consortium partners Breast Awareness Clinic, Prevent Breast Cancer, and Antegenes Ltd.

  • The service is supported by Prevent Breast Cancer – the UK charity committed solely to predicting and preventing breast cancer.
  • The service is organised and coordinated by Antegenes Ltd, UK. Antegenes is a an ISO 13485-certified European cross-border healthcare service provider headquartered in Estonia. Its personalised cancer prevention is offered as a cross-border healthcare service with healthcare licences L05386 & L04683.
  • Polygenic risk score analysis is performed using the CE-IVD certified AnteBC test (registered in the UK MHRA Registry GMDN code: 59918) provided by Antegenes.
  • The Breast Awareness Clinic provides optional post-test consultations and support for patients seeking personalised medical guidance.
  • Professor Gareth Evans is a Consultant Geneticist with a national and international reputation for his work in cancer genetics, particularly breast cancer. He is an important opinion leader on hereditary breast cancer and cancer syndromes. Prof Evans offers optional additional consultations at The Christie Private Care, Manchester.

 

 

 

Featured in

Our story

“Breast cancer is a devastating disease that affects too many people – the patients, their families, friends and colleagues. It is a disease that can often be cured if caught early and suitable treatments are prescribed. But what if there was no need for the cure? There was no diagnosis, no before or after breast cancer. What if people could live their lives safe in the knowledge that it would never happen to them.”

  • Lester Barr, MBE Co-Founder & Honorary President of Prevent Breast Cancer
illustration

“During my career as a doctor, I have seen and treated, in the team with my colleagues, thousands of cancer patients. We have been able to cure many of them. We have been able to give additional life to majority of them. But also, we have not been able to cure completely many of them. We have implemented many new effective cancer therapies and improved the quality of cancer care. But all the time I have been aware that the best cancer cases are these we could avoid. Or, if this is impossible to prevent, we could detect as early as possible, to implement as effective therapy as possible.

As cancer is a genetic disease, developments in basic research have opened new avenues for us to use genetic information in the prevention and early detection of cancer. With these developments, I became aware that we have to implement this new genetic information into cancer prevention as well as possible. After all, our good health and longevity is essential.”

  • Peeter Padrik, MD, PhD Oncologist

Laura Naylor is a Senior Breast Clinical Nurse Specialist and founder of The Breast Awareness Clinic. She has 15 years of experience in the diagnosis and treatment of breast cancer. Her mission has been to empower and educate individuals about breast health. The Breast Awareness Clinic is dedicated to supporting everyone—regardless of gender or background—through education and personalised care.

Laura offers consultations that do more than just teach self-examination; she provides comprehensive evaluations and insights into reducing breast cancer risks. Her goal is to make you feel informed, confident, and supported throughout your health journey. Thank you for joining us in this important step towards better health and well-being.

  • Laura Naylor Founder of The Breast Awareness Clinic; Senior Breast Clinical Nurse Specialist

A Consultant at Manchester University Hospitals NHS Foundation Trust and The Christie NHS Foundation Trust, Professor Gareth Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in breast cancer. Professor Evans is a chair of medical genetics and cancer epidemiology at the University of Manchester. He has published 940 peer reviewed research publications, 330 as first or senior author. Professor Evans is also lead clinician on the NICE Familial Breast Cancer Guideline Group and is a trustee of BCN and the Neuro Foundation.

  • Prof. Gareth Evans, MB, BS, MD, FRCP, FLSW, FRCOG, ad eundem Consultant Geneticist

Trusted by healthcare institutions across Europe

Prevent
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.